Radiation therapy firm Varian Medical Systems will highlight the latest version of its Vitesse real-time treatment planning software for high-dose-rate (HDR) brachytherapy at next week's American Society for Radiation Oncology (ASTRO) meeting in Boston.
Vitesse 3.0, which is pending U.S. Food and Drug Administration (FDA) 510(k) clearance, will allow HDR brachytherapy treatments to be planned and performed in the operating room using real-time ultrasound guidance, according to Varian.
